BackSoliton Overview

Soliton Profit Margin

Soliton (SOLY) has a profit margin of -4831.89%, below the Healthcare sector average of 13.89%.

Get informed when a big investor buys or sells

+ Follow

Quarterly Profit Margin

-73.51%

As of Sep 2021

Annual Profit Margin (TTM)

-4831.89%

Trailing 12 months ending Sep 2021

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading

Soliton (SOLY) FAQ

Soliton (SOLY) currently reports a profit margin of -4831.89% as of September 2021. That is below the Healthcare sector average of 13.89%. Use the charts on this page to explore Soliton's profit margin history and peer comparisons.

Soliton's profit margin of -4831.89% is lower than the Healthcare sector average of 13.89%. That is roughly 34899.1% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Soliton's current -4831.89% should be judged against Healthcare norms (sector average: 13.89%) and against SOLY's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -4831.89%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.89%. From there, open related valuation or income-statement pages for Soliton, and consider following SOLY for alerts when major investors trade the stock.

Soliton is classified in the Healthcare sector. On profit margin, it currently shows -4831.89% versus a sector average near 13.89%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SOLY with unrelated industries.